Literature DB >> 24280747

TGF-β-induced signaling circuit loops mediated by microRNAs as new therapeutic targets for renal fibrosis?

Mitsuo Kato1.   

Abstract

MicroRNAs (miRNAs) are emerging molecules in the pathogenesis of human diseases. Identification of miRNAs related to renal fibrosis provides clues to find new signaling pathways to fill the gaps between signaling molecules. Li et al. report another new pathway mediated by miR-433 that is induced by transforming growth factor-β1 in mouse models of renal fibrosis. The signaling also makes a positive-feedback circuit loop, which could be translated into new therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24280747     DOI: 10.1038/ki.2013.297

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Emerging role of miRNAs in renal fibrosis.

Authors:  Youling Fan; Hongtao Chen; Zhenxing Huang; Hong Zheng; Jun Zhou
Journal:  RNA Biol       Date:  2019-09-24       Impact factor: 4.652

Review 2.  Epigenetics in Kidney Transplantation: Current Evidence, Predictions, and Future Research Directions.

Authors:  Valeria R Mas; Thu H Le; Daniel G Maluf
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

3.  microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic-ischemic conditions in vitro.

Authors:  Yue Xing; Jingying Hou; Tianzhu Guo; Shaoxin Zheng; Changqing Zhou; Hui Huang; Yuyang Chen; Kan Sun; Tingting Zhong; Jingfeng Wang; Honghao Li; Tong Wang
Journal:  Stem Cell Res Ther       Date:  2014-11-23       Impact factor: 6.832

4.  Inhibition of miRNA‑135a‑5p ameliorates TGF‑β1‑induced human renal fibrosis by targeting SIRT1 in diabetic nephropathy.

Authors:  Juan Zhang; Lian Zhang; Dongqing Zha; Xiaoyan Wu
Journal:  Int J Mol Med       Date:  2020-06-17       Impact factor: 4.101

5.  miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction.

Authors:  Ryuji Morizane; Shizuka Fujii; Toshiaki Monkawa; Ken Hiratsuka; Shintaro Yamaguchi; Koichiro Homma; Hiroshi Itoh
Journal:  Sci Rep       Date:  2014-04-03       Impact factor: 4.379

6.  The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout mice.

Authors:  Jingjing Li; Meiping Guan; Chenzhong Li; Fuping Lyv; Yanmei Zeng; Zongji Zheng; Chengzhi Wang; Yaoming Xue
Journal:  Int J Mol Sci       Date:  2014-06-26       Impact factor: 5.923

7.  Potential role of ACE2-related microRNAs in COVID-19-associated nephropathy.

Authors:  Ahmedz Widiasta; Yunia Sribudiani; Husna Nugrahapraja; Dany Hilmanto; Nanan Sekarwana; Dedi Rachmadi
Journal:  Noncoding RNA Res       Date:  2020-09-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.